Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
AbCellera Biologics Inc. (ABCL)
USD6.82
+0.08 (+1.12%)
CA NASDAQ Healthcare Biotechnology
Address
2215 Yukon Street V5Y 0A1
Vancouver, BC, CA
Vancouver, BC, CA
CEO
Carl Hansen
Website
abcellera.com
IPO
2020-12-11
CIK 1703057 ISIN CA00288U1066
Description
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
News Sentiment (7d)
3 articles
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD6.82
+0.08 (+1.12%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
8M
Beta
1.20
Float Shares
203.83M
Free Float %
67.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.19% | +3.96% | +48.31% | +78.57% | +32.24% | +53.51% | +154.85% | -8.54% | -82.91% | -91.09% | -91.09% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
6.82
Low
7.00
+2.7%
Consensus
7.00
+2.7%
Median
7.00
+2.7%
High
7.00
+2.7%
Ratings Trend (MoM)
89% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
7.00
+2.7%
|
| Last Quarter | 1 |
7.00
+2.7%
|
| Last Year | 1 |
7.00
+2.7%
|
| All Time | 8 |
16.88
+147.7%
|
Quality scores
Altman Z-Score
3.12
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+160.6% ★ Q1'26: +96.3% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+10.9% Q1'26: +6.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-289.0% Q1'26: -449.2% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-236.4% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-24.5% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+1.5% ★ Q1'26: +1.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.92× Q1'26: -0.79× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 6 Rev. Ana. 4 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
233.16M
est: 212.90M (+9.5%)
|
375.20M
est: 354.36M (+5.9%)
|
485.42M
est: 519.16M (-6.5%)
|
38.03M
est: 33.05M (+15.0%)
|
28.83M
est: 31.58M (-8.7%)
|
75.13M
est: 36.30M (+107.0%)
|
30.17M
23.26M – 35.45M
-16.9% YoY
|
35.96M
28.09M – 40.18M
+19.2% YoY
|
46.89M
34.20M – 68.23M
+30.4% YoY
|
74.56M
54.38M – 108.48M
+59.0% YoY
|
128.92M
94.04M – 187.58M
+72.9% YoY
|
| EBITDA |
169.62M
est: -4.22M (+4,116.3%)
|
239.15M
est: -7.03M (+3,502.3%)
|
260.17M
est: -10.30M (+2,626.4%)
|
-192.16M
est: -12.08M (-1,491.3%)
|
-204.15M
est: -11.54M (-1,669.4%)
|
-155.42M
est: -13.26M (-1,072.1%)
|
-11.02M
-12.95M – -8.50M
+16.9% YoY
|
-13.14M
-14.68M – -10.26M
-19.2% YoY
|
-17.13M
-24.93M – -12.50M
-30.4% YoY
|
-27.24M
-39.63M – -19.87M
-59.0% YoY
|
-47.10M
-68.53M – -34.36M
-72.9% YoY
|
| EBIT |
164.34M
est: -10.05M (+1,735.7%)
|
221.90M
est: -16.72M (+1,426.9%)
|
227.07M
est: -24.50M (+1,026.8%)
|
-223.05M
est: -12.83M (-1,638.5%)
|
-301.15M
est: -12.26M (-2,356.6%)
|
-177.60M
est: -14.09M (-1,160.5%)
|
-11.71M
-13.76M – -9.03M
+16.9% YoY
|
-13.96M
-15.60M – -10.90M
-19.2% YoY
|
-18.20M
-26.48M – -13.28M
-30.4% YoY
|
-28.94M
-42.11M – -21.11M
-59.0% YoY
|
-50.04M
-72.81M – -36.50M
-72.9% YoY
|
| Net Income |
118.92M
est: 176.01M (-32.4%)
|
153.46M
est: 154.18M (-0.5%)
|
158.52M
est: 196.57M (-19.4%)
|
-146.40M
est: -153.30M (+4.5%)
|
-162.86M
est: -165.67M (+1.7%)
|
-146.41M
est: -170.58M (+14.2%)
|
-204.19M
-220.25M – -188.13M
-19.7% YoY
|
-217.64M
-219.93M – -215.35M
-6.6% YoY
|
-237.18M
-269.45M – -204.90M
-9.0% YoY
|
-224.03M
-356.55M – -145.23M
+5.5% YoY
|
-186.69M
-297.12M – -121.03M
+16.7% YoY
|
| SGA |
15.75M
est: 224.71M (-93.0%)
|
48.76M
est: 374.00M (-87.0%)
|
66.76M
est: 547.93M (-87.8%)
|
75.18M
est: 41.76M (+80.0%)
|
85.49M
est: 39.90M (+114.2%)
|
83.23M
est: 45.86M (+81.5%)
|
38.12M
29.39M – 44.79M
-16.9% YoY
|
45.43M
35.49M – 50.76M
+19.2% YoY
|
59.25M
43.22M – 86.20M
+30.4% YoY
|
94.20M
68.71M – 137.06M
+59.0% YoY
|
162.89M
118.82M – 237.01M
+72.9% YoY
|
| EPS |
0.32
est: 0.60 (-46.5%)
|
0.56
est: 0.52 (+6.9%)
|
0.56
est: 0.67 (-16.2%)
|
-0.51
est: -0.53 (+2.9%)
|
-0.55
est: -0.59 (+6.3%)
|
-0.49
est: -0.58 (+15.5%)
|
-0.69
-0.74 – -0.63
-19.2% YoY
|
-0.73
-0.74 – -0.72
-5.4% YoY
|
-0.82
-0.90 – -0.69
-12.2% YoY
|
-0.75
-1.19 – -0.49
+8.3% YoY
|
-0.63
-0.99 – -0.41
+16.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-125.85M
OE per share TTM
-0.42
Owner's Yield
-7.91%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
113.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
44
Total invested
33.12M
Insider transactions (90d)
0
Beneficial owners (>5%)
25
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Carl L.G. Hansen | 61.83M | 23.00% | 61.20M | 625.1K | 61.20M | 625.1K | IN | Canada | 2021-02-16 | ↗ |
| 2 | Thermopylae Holdings Ltd. | 61.20M | 22.70% | 61.20M | — | 61.20M | — | OO | Canada | 2021-02-16 | ↗ |
| 3 | DCVC Bio GP, LLC (“DCVC Bio GP”) | 29.11M | 10.80% | 29.11M | — | 29.11M | — | OO | Delaware | 2021-02-09 | ↗ |
| 4 | DCVC Bio, L.P. (“DCVC Bio”) | 29.11M | 10.80% | 29.11M | — | 29.11M | — | PN | Delaware | 2021-02-09 | ↗ |
| 5 | JNK Capital Management, LLC (“JNK”) | 29.11M | 10.80% | — | 29.11M | — | 29.11M | OO | Delaware | 2021-02-09 | ↗ |
| 6 | John Hamer (“Hamer”) | 29.11M | 10.80% | — | 29.11M | — | 29.11M | IN | U.S. Citizen | 2021-02-09 | ↗ |
| 7 | Kiersten Stead (“Stead”) | 29.11M | 10.80% | — | 29.11M | — | 29.11M | IN | U.S. Citizen | 2021-02-09 | ↗ |
| 8 | Matthew Ocko (“Ocko”) | 29.11M | 10.80% | — | 29.11M | — | 29.11M | IN | U.S. Citizen | 2021-02-09 | ↗ |
| 9 | ZNM Capital Management, LLC (“ZNM”) | 29.11M | 10.80% | — | 29.11M | — | 29.11M | OO | Delaware | 2021-02-09 | ↗ |
| 10 | Zachary Bogue (“Bogue”) | 29.11M | 10.80% | — | 29.11M | — | 29.11M | IN | U.S. Citizen | 2021-02-09 | ↗ |
| 11 | Baker Bros. Advisors (GP) LLC | 22.91M | 7.90% | 22.91M | — | 22.91M | — | HC, OO | Delaware | 2024-02-14 | ↗ |
| 12 | Baker Bros. Advisors LP | 22.91M | 7.90% | 22.91M | — | 22.91M | — | IA, PN | Delaware | 2024-02-14 | ↗ |
| 13 | Felix J. Baker | 22.91M | 7.90% | 22.91M | — | 22.91M | — | HC, IN | United States | 2024-02-14 | ↗ |
| 14 | Julian C. Baker | 22.91M | 7.90% | 22.91M | — | 22.91M | — | HC, IN | United States | 2024-02-14 | ↗ |
| 15 | Baillie Gifford & Co (Scottish partnership) | 19.70M | 11.00% | — | — | — | — | IA | SCOTLAND UK | 2023-01-18 | ↗ |
| 16 | Andreas Halvorsen | 19.28M | 7.20% | — | 19.28M | — | — | IN | Norway | 2020-12-28 | ↗ |
| 17 | C. Ott | 19.28M | 7.20% | — | 19.28M | — | — | IN | United States | 2020-12-28 | ↗ |
| 18 | S. Shabet | 19.28M | 7.20% | — | 19.28M | — | — | IN | United States | 2020-12-28 | ↗ |
| 19 | Viking Global Opportunities GP LLC | 19.28M | 7.20% | — | 19.28M | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 20 | Viking Global Opportunities Portfolio GP LLC | 18.92M | 7.00% | — | 18.92M | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 21 | Viking Global Opportunities Illiquid Investments Sub-Master LP | 18.72M | 7.00% | — | 18.72M | — | — | PN | Cayman Islands | 2020-12-28 | ↗ |
| 22 | DRAGSA 76 LLC | 361.8K | 0.10% | — | 361.8K | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 23 | Viking Global Opportunities Liquid Portfolio Sub-Master LP | 200.0K | 0.10% | — | 200.0K | — | — | PN | Cayman Islands | 2020-12-28 | ↗ |
| 24 | 95-1411037 | 13.00 | 7.80% | 22.05M | — | 22.05M | — | IA | Delaware | 2022-02-11 | ↗ |
| 25 | Viking Global Investors LP | — | 0.00% | — | — | — | — | PN | Delaware | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
44
-111 vs prev Q
New positions
7
Closed positions
110
Increased
24
Reduced
3
Put/Call ratio
54.72
Calls held
50.0K
Puts held
2.74M
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NVERSES CAPITAL, LLC | 35.4K +35.4K (+100.0%) | 121.23M +121.2M (+100.0%) | 0.01% +0.012 pp | 0.27% +0.272 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 2 | BAKER BROS. ADVISORS LP | 27.53M +— (+0.0%) | 94.14M -44.3M (-32.0%) | 9.21% -0.011 pp | 0.55% -0.449 pp | USD18.60 -81.6% | 21 qtrs — |
| 3 | CAPITAL WORLD INVESTORS | 13.36M +— (+0.0%) | 45.69M -21.5M (-32.0%) | 4.47% -0.006 pp | 0.01% -0.003 pp | USD2.65 +29.1% | 21 qtrs — |
| 4 | UBS ASSET MANAGEMENT AMERICAS INC | 7.88M +7.9M (+100.0%) | 26.94M +26.9M (+100.0%) | 2.64% +2.635 pp | 0.01% +0.006 pp | USD3.42 +0.0% | 7 qtrs — |
| 5 | TWO SIGMA INVESTMENTS, LP | 5.81M +635.8K (+12.3%) | 19.87M -6.2M (-23.7%) | 1.94% +0.211 pp | 0.03% -0.011 pp | USD4.79 -28.6% | 20 qtrs — |
| 6 | TWO SIGMA ADVISERS, LP | 4.88M +78.1K (+1.6%) | 16.68M -7.5M (-30.9%) | 1.63% +0.024 pp | 0.03% -0.016 pp | USD4.62 -26.0% | 16 qtrs — |
| 7 | GOLDMAN SACHS GROUP INC | 4.34M +4.1M (+1,636.3%) | 14.86M +13.6M (+1,080.5%) | 1.45% +1.370 pp | 0.00% +0.002 pp | USD3.45 -0.9% | 20 qtrs — |
| 8 | ARROWMARK COLORADO HOLDINGS LLC | 4.11M +— (+0.0%) | 14.04M -6.6M (-32.0%) | 1.37% -0.002 pp | 0.31% -0.075 pp | USD6.46 -47.1% | 11 qtrs — |
| 9 | BLACKROCK, INC. | 3.87M +224.1K (+6.2%) | 13.22M -5.1M (-27.8%) | 1.29% +0.074 pp | 0.00% 0.000 pp | USD2.68 +27.6% | 6 qtrs — |
| 10 | DRIEHAUS CAPITAL MANAGEMENT LLC | 3.77M +2.0M (+118.4%) | 12.90M +4.2M (+48.5%) | 1.26% +0.684 pp | 0.09% +0.025 pp | USD3.95 -13.4% | 3 qtrs — |
| 11 | MORGAN STANLEY | 3.00M +209.7K (+7.5%) | 10.27M -3.8M (-26.9%) | 1.00% +0.069 pp | 0.00% 0.000 pp | USD5.08 -32.7% | 21 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 2.63M +214.6K (+8.9%) | 9.00M -3.2M (-26.0%) | 0.88% +0.071 pp | 0.00% 0.000 pp | USD4.77 -28.3% | 19 qtrs — |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 2.39M -971.5K (-28.9%) | 8.17M -8.7M (-51.7%) | 0.80% -0.326 pp | 0.01% -0.010 pp | USD5.44 -37.1% | 19 qtrs — |
| 14 | UBS GROUP AG | 1.94M -549.8K (-22.1%) | 6.63M -5.9M (-47.0%) | 0.65% -0.185 pp | 0.00% -0.001 pp | USD2.51 +36.3% | 20 qtrs — |
| 15 | TUDOR INVESTMENT CORP ET AL | 1.80M +1.1M (+146.0%) | 6.14M +2.5M (+67.3%) | 0.60% +0.356 pp | 0.01% +0.005 pp | USD4.07 -16.0% | 2 qtrs — |
| 16 | MILLENNIUM MANAGEMENT LLC | 1.77M -656.2K (-27.0%) | 6.07M -6.2M (-50.4%) | 0.59% -0.221 pp | 0.00% -0.003 pp | USD3.64 -6.0% | 21 qtrs — |
| 17 | GUARDIAN PARTNERS INC. | 1.79M +— (+0.0%) | 5.82M -4.8M (-45.3%) | 0.60% -0.001 pp | 0.47% -0.435 pp | USD2.93 +16.7% | 5 qtrs — |
| 18 | JANE STREET GROUP, LLC | 1.40M +999.9K (+251.8%) | 4.78M +2.8M (+139.2%) | 0.47% +0.334 pp | 0.00% +0.000 pp | USD3.77 -9.3% | 21 qtrs — |
| 19 | POINT72 ASSET MANAGEMENT, L.P. | 976.5K +976.5K (+100.0%) | 3.34M +3.3M (+100.0%) | 0.33% +0.327 pp | 0.00% +0.004 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 20 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 695.8K +438.1K (+170.0%) | 2.38M +1.1M (+83.6%) | 0.23% +0.147 pp | 0.01% +0.004 pp | USD4.02 -14.9% | 2 qtrs — |
| 21 | STATE STREET CORP | 694.1K +23.1K (+3.4%) | 2.37M -1.0M (-29.7%) | 0.23% +0.008 pp | 0.00% +0.000 pp | USD5.17 -33.8% | 18 qtrs — |
| 22 | HRT FINANCIAL LP | 548.4K +111.9K (+25.6%) | 1.88M -320.0K (-14.6%) | 0.18% +0.037 pp | 0.01% -0.002 pp | USD3.38 +1.2% | 6 qtrs — |
| 23 | INTELLECTUS PARTNERS, LLC | 523.4K -19.8K (-3.6%) | 1.79M -942.0K (-34.5%) | 0.18% -0.007 pp | 0.35% -0.183 pp | USD21.39 -84.0% | 19 qtrs — |
| 24 | STATE OF MICHIGAN RETIREMENT SYSTEM | 400.0K +— (+0.0%) | 1.37M -644.0K (-32.0%) | 0.13% 0.000 pp | 0.01% -0.003 pp | USD4.83 -29.2% | 3 qtrs — |
| 25 | ROYAL BANK OF CANADA | 373.9K -130.1K (-25.8%) | 1.28M -1.3M (-49.5%) | 0.13% -0.044 pp | 0.00% 0.000 pp | USD11.75 -70.9% | 21 qtrs — |
| 26 | XTX TOPCO LTD | 363.3K +363.3K (+100.0%) | 1.24M +1.2M (+100.0%) | 0.12% +0.122 pp | 0.03% +0.033 pp | USD3.42 +0.0% | 7 qtrs — |
| 27 | ADVISOR GROUP HOLDINGS, INC. | 347.3K +4.2K (+1.2%) | 1.19M -247.3K (-17.2%) | 0.12% +0.001 pp | 0.00% 0.000 pp | USD4.82 -29.0% | 21 qtrs — |
| 28 | SOFTBANK GROUP CORP. | 345.2K +345.2K (+100.0%) | 1.18M +1.2M (+100.0%) | 0.12% +0.116 pp | 0.01% +0.008 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 29 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 340.3K +— (+0.0%) | 1.16M -547.8K (-32.0%) | 0.11% 0.000 pp | 0.00% -0.002 pp | USD4.01 -14.7% | 11 qtrs — |
| 30 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 336.8K +38.1K (+12.8%) | 1.15M -350.6K (-23.3%) | 0.11% +0.013 pp | 0.00% +0.000 pp | USD5.31 -35.6% | 20 qtrs — |
| 31 | LAZARD ASSET MANAGEMENT LLC | 328.7K -323.4K (-49.6%) | 1.12M -2.2M (-65.7%) | 0.11% -0.109 pp | 0.00% -0.003 pp | USD8.70 -60.7% | 18 qtrs — |
| 32 | GEODE CAPITAL MANAGEMENT, LLC | 313.5K -15.8K (-4.8%) | 1.07M -583.9K (-35.3%) | 0.10% -0.005 pp | 0.00% +0.000 pp | USD4.55 -24.8% | 21 qtrs — |
| 33 | VOLEON CAPITAL MANAGEMENT LP | 265.3K +254.1K (+2,269.0%) | 907.4K +851.1K (+1,510.7%) | 0.09% +0.085 pp | 0.02% +0.018 pp | USD3.49 -2.0% | 2 qtrs — |
| 34 | CITIZENS FINANCIAL GROUP INC/RI | 261.9K +— (+0.0%) | 895.7K -421.6K (-32.0%) | 0.09% 0.000 pp | 0.01% -0.006 pp | USD5.03 -32.0% | 2 qtrs — |
| 35 | GRAHAM CAPITAL MANAGEMENT, L.P. | 257.8K +231.7K (+887.4%) | 881.8K +750.5K (+571.4%) | 0.09% +0.078 pp | 0.02% +0.019 pp | USD3.42 +0.0% | 5 qtrs — |
| 36 | WALLEYE CAPITAL LLC | 249.1K +249.1K (+100.0%) | 851.8K +851.8K (+100.0%) | 0.08% +0.083 pp | 0.00% +0.003 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 37 | RAYMOND JAMES FINANCIAL INC | 247.1K +208.6K (+543.1%) | 844.9K +651.7K (+337.2%) | 0.08% +0.070 pp | 0.00% +0.000 pp | USD3.43 -0.3% | 5 qtrs — |
| 38 | IEQ CAPITAL, LLC | 246.0K +— (+0.0%) | 841.2K -396.0K (-32.0%) | 0.08% 0.000 pp | 0.00% -0.001 pp | USD5.03 -32.0% | 2 qtrs — |
| 39 | CITADEL ADVISORS LLC | 222.0K -15.3K (-6.4%) | 759.2K -434.4K (-36.4%) | 0.07% -0.005 pp | 0.00% 0.000 pp | USD5.01 -31.7% | 20 qtrs — |
| 40 | BNP PARIBAS ARBITRAGE, SNC | 211.3K +64.5K (+43.9%) | 722.6K -15.7K (-2.1%) | 0.07% +0.022 pp | 0.00% 0.000 pp | USD4.48 -23.7% | 5 qtrs — |
| 41 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 209.9K -527.0K (-71.5%) | 717.9K -3.0M (-80.6%) | 0.07% -0.177 pp | 0.00% -0.002 pp | USD5.03 -32.0% | 2 qtrs — |
| 42 | NORTHERN TRUST CORP | 208.1K -10.0K (-4.6%) | 711.6K -385.1K (-35.1%) | 0.07% -0.003 pp | 0.00% +0.000 pp | USD4.76 -28.2% | 15 qtrs — |
| 43 | QUADRATURE CAPITAL LTD | 205.1K +205.1K (+100.0%) | 701.4K +701.4K (+100.0%) | 0.07% +0.069 pp | 0.01% +0.007 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 44 | HEADLANDS TECHNOLOGIES LLC | 188.8K +69.2K (+57.9%) | 645.7K +44.1K (+7.3%) | 0.06% +0.023 pp | 0.05% +0.006 pp | USD4.12 -17.0% | 3 qtrs — |
| 45 | VIRTU FINANCIAL LLC | 181.0K +181.0K (+100.0%) | 619.0K +619.0K (+100.0%) | 0.06% +0.061 pp | 0.02% +0.024 pp | USD3.42 +0.0% | 4 qtrs — |
| 46 | — | 182.5K +182.5K (+100.0%) | 617.3K +617.3K (+100.0%) | 0.06% +0.061 pp | 0.04% +0.035 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 47 | NORGES BANK | 176.4K +176.4K (+100.0%) | 603.2K +603.2K (+100.0%) | 0.06% +0.059 pp | 0.00% +0.000 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 48 | BANK OF MONTREAL /CAN/ | 146.4K +80.9K (+123.4%) | 500.5K +171.0K (+51.9%) | 0.05% +0.027 pp | 0.00% +0.000 pp | USD5.30 -35.5% | 21 qtrs — |
| 49 | AQUATIC CAPITAL MANAGEMENT LLC | 141.9K -17.5K (-11.0%) | 485.2K -316.6K (-39.5%) | 0.05% -0.006 pp | 0.01% -0.001 pp | USD5.03 -32.0% | 2 qtrs — |
| 50 | SQUAREPOINT OPS LLC | 133.1K +30.6K (+29.9%) | 455.1K -60.3K (-11.7%) | 0.04% +0.010 pp | 0.00% +0.000 pp | USD4.57 -25.2% | 20 qtrs — |
| 51 | GROUP ONE TRADING, L.P. | 129.0K +8.0K (+6.6%) | 441.2K -167.6K (-27.5%) | 0.04% +0.003 pp | 0.00% 0.000 pp | USD3.24 +5.6% | 19 qtrs — |
| 52 | PEAK6 LLC | 125.7K +58.4K (+86.8%) | 429.9K +91.4K (+27.0%) | 0.04% +0.020 pp | 0.00% +0.000 pp | USD4.28 -20.1% | 4 qtrs — |
| 53 | DEKABANK DEUTSCHE GIROZENTRALE | 87.0K +— (+0.0%) | 425.0K +13.0K (+3.2%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD14.30 -76.1% | 17 qtrs — |
| 54 | QUBE RESEARCH & TECHNOLOGIES LTD | 122.6K +122.6K (+100.0%) | 419.3K +419.3K (+100.0%) | 0.04% +0.041 pp | 0.00% +0.000 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 55 | HSBC HOLDINGS PLC | 117.0K +92.4K (+375.4%) | 400.8K +278.2K (+227.0%) | 0.04% +0.031 pp | 0.00% +0.000 pp | USD3.86 -11.4% | 11 qtrs — |
| 56 | ARCHPOINT INVESTORS | 115.1K +— (+0.0%) | 393.5K -185.2K (-32.0%) | 0.04% +0.000 pp | 0.09% -0.066 pp | USD17.52 -80.5% | 18 qtrs — |
| 57 | AMERICAN CENTURY COMPANIES INC | 113.8K +— (+0.0%) | 389.1K -183.2K (-32.0%) | 0.04% +0.000 pp | 0.00% 0.000 pp | USD10.01 -65.8% | 14 qtrs — |
| 58 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 113.1K +113.1K (+100.0%) | 386.7K +386.7K (+100.0%) | 0.04% +0.038 pp | 0.00% +0.003 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 59 | PRELUDE CAPITAL MANAGEMENT, LLC | 109.0K +109.0K (+100.0%) | 372.8K +372.8K (+100.0%) | 0.04% +0.037 pp | 0.03% +0.027 pp | USD3.42 +0.0% | 3 qtrs — |
| 60 | PIER 88 INVESTMENT PARTNERS LLC | 105.7K -3.1K (-2.9%) | 361.6K -186.0K (-34.0%) | 0.04% -0.001 pp | 0.08% -0.022 pp | USD3.00 +14.0% | 8 qtrs — |
| 61 | POLEN CAPITAL MANAGEMENT LLC | 102.5K -166.7K (-61.9%) | 350.6K -1.0M (-74.1%) | 0.03% -0.056 pp | 0.00% -0.003 pp | USD5.03 -32.0% | 2 qtrs — |
| 62 | WALLEYE TRADING LLC | 97.2K +10.7K (+12.4%) | 332.4K -102.7K (-23.6%) | 0.03% +0.004 pp | 0.00% 0.000 pp | USD4.85 -29.5% | 2 qtrs — |
| 63 | STIFEL FINANCIAL CORP | 85.2K -17.6K (-17.1%) | 291.3K -225.7K (-43.7%) | 0.03% -0.006 pp | 0.00% 0.000 pp | USD8.57 -60.1% | 20 qtrs — |
| 64 | JUMP FINANCIAL, LLC | 81.3K -594.3K (-88.0%) | 277.9K -3.1M (-91.8%) | 0.03% -0.199 pp | 0.00% -0.037 pp | USD5.03 -32.0% | 2 qtrs — |
| 65 | HIGHTOWER ADVISORS, LLC | 80.0K +49.8K (+164.7%) | 273.5K +121.5K (+80.0%) | 0.03% +0.017 pp | 0.00% +0.000 pp | USD3.71 -7.8% | 10 qtrs — |
| 66 | HANDELSBANKEN FONDER AB | 79.3K +79.3K (+100.0%) | 271.0K +271.0K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.001 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 67 | D. E. SHAW & CO., INC. | 77.8K +1.3K (+1.7%) | 266.0K -118.7K (-30.9%) | 0.03% +0.000 pp | 0.00% 0.000 pp | USD3.95 -13.4% | 3 qtrs — |
| 68 | JPMORGAN CHASE & CO | 77.6K -53.1K (-40.6%) | 265.4K -391.8K (-59.6%) | 0.03% -0.018 pp | 0.00% +0.000 pp | USD9.22 -62.9% | 17 qtrs — |
| 69 | VIRTUS INVESTMENT ADVISERS, INC. | 73.5K +37.4K (+103.4%) | 251.3K +69.6K (+38.3%) | 0.02% +0.013 pp | 0.07% +0.016 pp | USD3.07 +11.4% | 4 qtrs — |
| 70 | TWO SIGMA SECURITIES, LLC | 68.3K +55.2K (+423.4%) | 233.5K +167.9K (+255.9%) | 0.02% +0.019 pp | 0.03% +0.022 pp | USD3.73 -8.3% | 2 qtrs — |
| 71 | ERSTE ASSET MANAGEMENT GMBH | 62.0K +— (+0.0%) | 214.5K -87.4K (-29.0%) | 0.02% +0.000 pp | 0.00% -0.001 pp | USD9.75 -64.9% | 16 qtrs — |
| 72 | RESOLUTE ADVISORS LLC | 57.5K +— (+0.0%) | 196.7K -92.6K (-32.0%) | 0.02% +0.000 pp | 0.06% -0.010 pp | USD16.74 -79.6% | 18 qtrs — |
| 73 | INVESCO LTD. | 54.6K +11.9K (+27.9%) | 186.7K -28.0K (-13.0%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD3.45 -0.9% | 8 qtrs — |
| 74 | CERITY PARTNERS LLC | 52.1K -1.0K (-1.9%) | 178.0K -88.8K (-33.3%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD3.73 -8.3% | 11 qtrs — |
| 75 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 48.8K -3.6K (-6.9%) | 166.8K -96.7K (-36.7%) | 0.02% -0.001 pp | 0.01% -0.009 pp | USD4.16 -17.8% | 14 qtrs — |
| 76 | LPL FINANCIAL LLC | 48.7K +13.0K (+36.2%) | 166.6K -13.3K (-7.4%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD4.00 -14.5% | 3 qtrs — |
| 77 | TRADITION WEALTH MANAGEMENT, LLC | 47.1K +11.0K (+30.4%) | 161.1K -20.7K (-11.4%) | 0.02% +0.004 pp | 0.01% -0.002 pp | USD4.66 -26.6% | 2 qtrs — |
| 78 | XML FINANCIAL, LLC | 42.0K +— (+0.0%) | 143.7K -67.7K (-32.0%) | 0.01% +0.000 pp | 0.01% -0.006 pp | USD3.72 -8.1% | 3 qtrs — |
| 79 | CREATIVE PLANNING | 41.8K -5.9K (-12.3%) | 143.1K -97.0K (-40.4%) | 0.01% -0.002 pp | 0.00% 0.000 pp | USD3.12 +9.6% | 11 qtrs — |
| 80 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 39.9K -3.8K (-8.7%) | 136.1K -83.2K (-37.9%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD6.12 -44.1% | 19 qtrs — |
| 81 | SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | 35.7K -3.0K (-7.8%) | 122.0K -72.5K (-37.3%) | 0.01% -0.001 pp | 0.00% -0.002 pp | USD2.78 +23.0% | 7 qtrs — |
| 82 | BARCLAYS PLC | 33.5K +11.3K (+50.5%) | 114.7K +56.8K (+97.9%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD3.95 -13.4% | 16 qtrs — |
| 83 | ADVISORY SERVICES NETWORK, LLC | 29.7K +3.4K (+12.9%) | 101.5K -30.7K (-23.2%) | 0.01% +0.001 pp | 0.00% -0.001 pp | USD4.85 -29.5% | 2 qtrs — |
| 84 | BRANDYWINE MANAGERS, LLC | 28.5K +— (+0.0%) | 97.4K -45.9K (-32.0%) | 0.01% +0.000 pp | 0.05% -0.089 pp | USD22.00 -84.5% | 21 qtrs — |
| 85 | GREEN ALPHA ADVISORS, LLC | 27.6K +4.8K (+21.2%) | 94.4K -20.2K (-17.6%) | 0.01% +0.002 pp | 0.09% -0.024 pp | USD7.59 -54.9% | 18 qtrs — |
| 86 | RESOURCES INVESTMENT ADVISORS, LLC. | 24.0K +13.8K (+134.1%) | 82.1K +30.5K (+59.2%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD4.11 -16.8% | 2 qtrs — |
| 87 | HBK SORCE ADVISORY LLC | 25.0K +25.0K (+100.0%) | 78.9K +78.9K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.002 pp | USD3.42 +0.0% | 1 qtrs NEW |
| 88 | STRATOS WEALTH ADVISORS, LLC | 23.0K +4.0K (+21.1%) | 78.7K -16.9K (-17.7%) | 0.01% +0.001 pp | 0.00% -0.001 pp | USD4.75 -28.0% | 10 qtrs — |
| 89 | TD WATERHOUSE CANADA INC. | 22.4K -2.1K (-8.7%) | 76.4K -69.9K (-47.8%) | 0.01% -0.001 pp | 0.00% -0.001 pp | USD10.30 -66.8% | 17 qtrs — |
| 90 | CIBC WORLD MARKET INC. | 20.7K +4.3K (+26.5%) | 70.8K -11.5K (-14.0%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD11.66 -70.7% | 20 qtrs — |
| 91 | TOWER RESEARCH CAPITAL LLC (TRC) | 20.1K +14.9K (+288.0%) | 68.7K +42.6K (+163.8%) | 0.01% +0.005 pp | 0.00% +0.001 pp | USD3.51 -2.6% | 21 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 17 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Northern Lights Fund Trust III - Counterpoint Quantitative Equity ETF CPAI | 1.93% | 7.20M | 0.75% |
| 2 | iShares Genomics Immunology and Healthcare ETF IDNA | 1.75% | 3.43M | 0.47% |
| 3 | Virtus Biotech Clinical Trials ETF BBC | 0.80% | 459.8K | 0.65% |
| 4 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.18% | 2.08M | 0.40% |
| 5 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.14% | 660.8K | 0.40% |
| 6 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.14% | 106.7K | 0.19% |
| 7 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.14% | 104.6K | 0.35% |
| 8 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.14% | 1.56M | 0.35% |
| 9 | State Street SPDR S&P International Small Cap ETF GWX | 0.13% | 1.13M | 0.40% |
| 10 | iShares Biotechnology ETF IBB | 0.12% | 11.47M | 0.44% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
4.21M
Shares disposed
—
Cash buys
2.00
Cash sales
—
Net activity
+4,213,990
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 38,000 | 3.44 | 130.7K | 56,134,097 | D | ↗ |
| 2026-02-27 | Booth Andrew | Officer | P-Purchase | A | Common Shares | 42,600 | 3.42 | 145.7K | 195,600 | D | ↗ |
| 2026-02-26 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 177,457 | 3.27 | 580.3K | 56,096,097 | D | ↗ |
| 2026-01-01 | Stimart Tryn | Officer | A-Award | A | Share option (right to buy) | 539,265 | 3.42 | 1.84M | 4,646,012 | D | ↗ |
| 2026-01-01 | Lecault Veronique | Director / Officer | A-Award | A | Share option (right to buy) | 539,265 | 3.42 | 1.84M | 5,201,069 | D | ↗ |
| 2026-01-01 | Hansen Carl L. G. | Director / Officer / 10% Owner | A-Award | A | Share option (right to buy) | 2,106,505 | 3.42 | 7.20M | 13,096,837 | D | ↗ |
| 2026-01-01 | Booth Andrew | Officer | A-Award | A | Share option (right to buy) | 808,898 | 3.42 | 2.77M | 8,751,849 | D | ↗ |
| 2025-12-18 | Thermopylae Holdings Ltd. | 10% Owner | G-Gift | D | Common Shares | 225,000 | 0.00 | — | 55,918,640 | D | ↗ |
| 2025-12-01 | Quake Stephen | Director | A-Award | A | Share option (right to buy) | 194,932 | 3.47 | 676.4K | 194,932 | D | ↗ |
| 2025-11-26 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 50,000 | 3.57 | 178.5K | 221,000 | D | ↗ |
| 2025-11-10 | Quake Stephen | Director | — | — | Common Shares | 0 | 0.00 | — | 264,300 | I | ↗ |
| 2025-06-12 | Montalbano John S. | Director | A-Award | A | Share option (right to buy) | 238,864 | 3.15 | 752.4K | 1,029,843 | D | ↗ |
| 2025-06-12 | Lo Andrew | Director | A-Award | A | Share option (right to buy) | 238,864 | 3.15 | 752.4K | 541,354 | D | ↗ |
| 2025-06-12 | Hayden Michael R | Director | A-Award | A | Share option (right to buy) | 238,864 | 3.15 | 752.4K | 899,843 | D | ↗ |
| 2025-03-11 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 343,631 | 2.16 | 742.2K | 56,143,640 | D | ↗ |
| 2025-03-10 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 25,000 | 2.30 | 57.5K | 171,000 | D | ↗ |
| 2025-03-06 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 60,000 | 2.34 | 140.6K | 146,000 | D | ↗ |
| 2025-01-01 | Stimart Tryn | Officer | A-Award | A | Share option (right to buy) | 832,033 | 2.93 | 2.44M | 4,106,747 | D | ↗ |
| 2025-01-01 | Lecault Veronique | Director / Officer | A-Award | A | Share option (right to buy) | 832,033 | 2.93 | 2.44M | 4,661,804 | D | ↗ |
| 2025-01-01 | Hansen Carl L. G. | Director / Officer / 10% Owner | A-Award | A | Share option (right to buy) | 2,730,109 | 2.93 | 8.00M | 10,990,332 | D | ↗ |
| 2025-01-01 | Booth Andrew | Officer | A-Award | A | Share option (right to buy) | 1,352,054 | 2.93 | 3.96M | 7,942,951 | D | ↗ |
| 2024-12-04 | Thermopylae Holdings Ltd. | 10% Owner | G-Gift | D | Common Shares | 286,000 | 0.00 | — | 55,800,009 | D | ↗ |
| 2024-11-25 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 8,260,223 | D | ↗ |
| 2024-09-20 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 8,316,348 | D | ↗ |
| 2024-08-29 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 283,516 | 2.61 | 740.0K | 56,086,009 | — | ↗ |
| 2024-06-21 | Montalbano John S. | Director | A-Award | A | Share option (right to buy) | 163,934 | 2.94 | 482.0K | 790,979 | — | ↗ |
| 2024-06-21 | Lo Andrew | Director | A-Award | A | Share option (right to buy) | 163,934 | 2.94 | 482.0K | 302,490 | — | ↗ |
| 2024-06-21 | Lecault Veronique | Director / Officer | M-Exempt | A | Common Shares | 83,334 | 0.19 | 15.7K | 2,123,456 | — | ↗ |
| 2024-06-21 | Hayden Michael R | Director | A-Award | A | Share option (right to buy) | 163,934 | 2.94 | 482.0K | 660,979 | — | ↗ |
| 2024-05-31 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 8,372,473 | — | ↗ |
| 2024-02-26 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 8,428,598 | — | ↗ |
| 2024-01-14 | Stimart Tryn | Officer | A-Award | A | Share option (right to buy) | 616,333 | 5.39 | 3.32M | 3,274,714 | — | ↗ |
| 2024-01-14 | Lecault Veronique | Director / Officer | A-Award | A | Share option (right to buy) | 770,416 | 5.39 | 4.15M | 3,913,105 | — | ↗ |
| 2024-01-14 | Hansen Carl L. G. | Director / Officer / 10% Owner | A-Award | A | Share option (right to buy) | 2,095,532 | 5.39 | 11.29M | 8,484,723 | — | ↗ |
| 2024-01-14 | Booth Andrew | Officer | A-Award | A | Share option (right to buy) | 770,416 | 5.39 | 4.15M | 6,590,897 | — | ↗ |
| 2023-12-19 | Thermopylae Holdings Ltd. | 10% Owner | G-Gift | D | Common Shares | 210,000 | 0.00 | — | 55,802,493 | — | ↗ |
| 2023-11-23 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 6,389,191 | — | ↗ |
| 2023-11-08 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 10,000 | 4.46 | 44.6K | 86,000 | — | ↗ |
| 2023-11-06 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 20,000 | 4.64 | 92.8K | 76,000 | — | ↗ |
| 2023-09-22 | Hayden Michael R | Director | P-Purchase | A | Common Shares | 20,000 | 4.91 | 98.2K | 1,323,397 | — | ↗ |
| 2023-09-12 | Lecault Veronique | Director / Officer | P-Purchase | A | Common Shares | 20,000 | 5.19 | 103.8K | 2,040,122 | — | ↗ |
| 2023-08-24 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 6,445,316 | — | ↗ |
| 2023-08-08 | Hayden Michael R | Director | P-Purchase | A | Common Shares | 30,000 | 5.90 | 177.0K | 1,303,397 | — | ↗ |
| 2023-05-26 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 153,000 | 6.52 | 997.7K | 56,012,493 | — | ↗ |
| 2023-05-26 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 6,501,441 | — | ↗ |
| 2023-05-26 | Booth Andrew | Officer | P-Purchase | A | Common Shares | 14,500 | 6.85 | 99.3K | 153,000 | — | ↗ |
| 2023-05-05 | Lecault Veronique | Director / Officer | M-Exempt | D | Share option (right to buy) | 250,000 | 0.19 | 47.5K | 3,142,689 | — | ↗ |
| 2023-02-22 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 6,557,566 | — | ↗ |
| 2022-12-20 | Booth Andrew | Officer | M-Exempt | D | Share option (right to buy) | 50,000 | 0.00 | — | 5,820,481 | — | ↗ |
| 2022-12-16 | Thermopylae Holdings Ltd. | Director | P-Purchase | A | Common Shares | 85,102 | 10.10 | 859.2K | 55,859,493 | — | ↗ |
| 2022-12-01 | Stimart Tryn | Officer | A-Award | A | Share Options (right to buy) | 346,901 | 0.00 | — | 2,658,381 | — | ↗ |
| 2022-12-01 | Montalbano John S. | Director | A-Award | A | Share option (right to buy) | 47,231 | 0.00 | — | 627,045 | — | ↗ |
| 2022-12-01 | Lo Andrew | Director | A-Award | A | Share Option (right to buy) | 47,231 | 0.00 | — | 138,556 | — | ↗ |
| 2022-12-01 | Lecault Veronique | Officer | A-Award | A | Share Options (right to buy) | 462,535 | 0.00 | — | 3,392,689 | — | ↗ |
| 2022-12-01 | Hayden Michael R | Director | A-Award | A | Share Option (right to buy) | 47,231 | 0.00 | — | 497,045 | — | ↗ |
| 2022-12-01 | Hansen Carl L. G. | Officer | A-Award | A | Share Options (right to buy) | 925,069 | 0.00 | — | 6,613,691 | — | ↗ |
| 2022-12-01 | Booth Andrew | Officer | A-Award | A | Share Options (right to buy) | 485,661 | 0.00 | — | 5,870,481 | — | ↗ |
| 2022-11-18 | Hansen Carl L. G. | Officer | M-Exempt | A | Common Shares | 56,125 | 2.70 | 151.5K | 449,000 | — | ↗ |
| 2022-10-31 | Thermopylae Holdings Ltd. | Director | G-Gift | D | Common Shares | 70,000 | 0.00 | — | 55,774,391 | — | ↗ |
| 2022-08-19 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 200,000 | 11.46 | 2.29M | 55,844,391 | — | ↗ |
| 2022-08-18 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | D | Share option (right to buy) | 56,125 | 2.70 | 151.5K | 5,744,747 | — | ↗ |
| 2022-06-14 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 9,173 | 8.05 | 73.8K | 55,644,391 | — | ↗ |
| 2022-06-13 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 54,915 | 8.03 | 441.1K | 55,635,218 | — | ↗ |
| 2022-06-06 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 64,545 | 7.50 | 484.0K | 55,580,303 | — | ↗ |
| 2022-05-18 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | A | Common Shares | 56,125 | 2.70 | 151.5K | 336,750 | — | ↗ |
| 2022-05-16 | Lecault Veronique | Director / Officer | P-Purchase | A | Common Shares | 200,000 | 6.34 | 1.27M | 1,770,122 | — | ↗ |
| 2022-05-13 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 300,000 | 7.26 | 2.18M | 55,515,758 | — | ↗ |
| 2022-05-12 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 1,408,468 | 6.41 | 9.02M | 55,215,758 | — | ↗ |
| 2022-05-12 | Booth Andrew | Officer | P-Purchase | A | Common Shares | 85,000 | 5.79 | 492.2K | 138,500 | — | ↗ |
| 2022-03-04 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 10,000 | 8.54 | 85.4K | 56,000 | — | ↗ |
| 2022-03-01 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 20,000 | 9.05 | 181.0K | 46,000 | — | ↗ |
| 2022-02-28 | Lecault Veronique | Director / Officer | P-Purchase | A | Common Shares | 230,789 | 8.66 | 2.00M | 1,570,122 | — | ↗ |
| 2022-02-22 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | A | Common Shares | 56,125 | 2.70 | 151.5K | 280,625 | — | ↗ |
| 2021-12-31 | Thermopylae Holdings Ltd. | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Lecault Veronique | Director / Officer | — | I | Common Shares | 0 | 0.00 | — | 61,580 | — | ↗ |
| 2021-12-31 | Hansen Carl L. G. | Director / Officer / 10% Owner | — | D | Common Shares | 0 | 0.00 | — | 224,500 | — | ↗ |
| 2021-12-31 | Booth Andrew | Officer | — | I | Common Shares | 0 | 0.00 | — | 130,959 | — | ↗ |
| 2021-12-10 | Booth Andrew | Officer | M-Exempt | D | Share Options (right to buy) | 500,000 | 0.32 | 160.0K | 5,384,820 | — | ↗ |
| 2021-12-08 | Lecault Veronique | Director / Officer | M-Exempt | D | Share Option (right to buy) | 250,000 | 0.19 | 47.5K | 2,524,134 | — | ↗ |
| 2021-12-07 | Stimart Tryn | Officer | A-Award | A | Share Option (right to buy) | 270,680 | 14.55 | 3.94M | 2,311,480 | — | ↗ |
| 2021-12-07 | Montalbano John S. | Director | A-Award | A | Share option (right to buy) | 45,532 | 14.55 | 662.5K | 579,814 | — | ↗ |
| 2021-12-07 | Lecault Veronique | Director / Officer | A-Award | A | Share Option | 406,020 | 14.55 | 5.91M | 2,930,154 | — | ↗ |
| 2021-12-07 | Hayden Michael R | Director | A-Award | A | Share option (right to buy) | 45,532 | 14.55 | 662.5K | 449,814 | — | ↗ |
| 2021-12-07 | Hansen Carl L. G. | Director / Officer / 10% Owner | A-Award | A | Share Option (right to buy) | 920,312 | 14.55 | 13.39M | 5,913,122 | — | ↗ |
| 2021-12-07 | Booth Andrew | Officer | A-Award | A | Share Option (right to buy) | 406,020 | 14.55 | 5.91M | 5,884,820 | — | ↗ |
| 2021-12-03 | Lo Andrew | Director | A-Award | A | Share Option (right to buy) | 91,325 | 14.02 | 1.28M | 91,325 | — | ↗ |
| 2021-11-30 | Lecault Veronique | Director / Officer | M-Exempt | A | Common Shares | 83,333 | 0.19 | 15.8K | 1,422,666 | — | ↗ |
| 2021-11-18 | Hansen Carl L. G. | Director / Officer / 10% Owner | M-Exempt | A | Common Shares | 224,500 | 15.03 | 3.37M | 224,500 | — | ↗ |
| 2021-11-11 | Thermopylae Holdings Ltd. | 10% Owner | P-Purchase | A | Common Shares | 202,960 | 14.76 | 3.00M | 55,807,290 | — | ↗ |
| 2021-11-11 | Booth Andrew | Officer | P-Purchase | A | Common Shares | 14,000 | 14.61 | 204.5K | 130,959 | — | ↗ |
| 2021-09-13 | Hayden Michael R | Director | M-Exempt | A | Share option (right to buy) | 270,000 | 0.32 | 86.4K | 270,000 | — | ↗ |
| 2021-09-01 | HAMER JOHN | Director | S-Sale | D | Common Shares | 137,351 | 16.93 | 2.33M | 128,862 | — | ↗ |
| 2021-09-01 | Falconer Ester | Officer | M-Exempt | A | Common Shares | 875,000 | 16.89 | 14.78M | 875,000 | — | ↗ |
| 2021-08-31 | HAMER JOHN | Director | S-Sale | D | Common Shares | 162,649 | 16.95 | 2.76M | 266,213 | — | ↗ |
| 2021-08-27 | Montalbano John S. | Director | A-Award | A | Share option (right to buy) | 34,282 | 17.58 | 602.7K | 534,282 | — | ↗ |
| 2021-08-27 | Hayden Michael R | Director | A-Award | A | Share option (right to buy) | 34,282 | 17.58 | 602.7K | 674,282 | — | ↗ |
| 2021-08-16 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 6,000 | 17.23 | 103.4K | 26,000 | — | ↗ |
| 2021-06-22 | Hayden Michael R | Director | S-Sale | D | Common Shares | 100,000 | 25.50 | 2.55M | 1,003,397 | — | ↗ |
| 2021-06-18 | HAMER JOHN | Director / 10% Owner | J-Other | A | Common Shares | 73,892 | 0.00 | — | 73,892 | — | ↗ |
| 2021-06-18 | DCVC Bio, L.P. | 10% Owner | J-Other | A | Common Shares | 73,892 | 0.00 | — | 73,892 | — | ↗ |
| 2021-06-15 | Lecault Veronique | Director / Officer | M-Exempt | A | Common Shares | 333,333 | 0.19 | 63.3K | 1,339,333 | — | ↗ |
| 2021-06-09 | Thermopylae Holdings Ltd. | 10% Owner | S-Sale | D | Common Shares | 5,598,420 | 24.03 | 134.53M | 55,604,330 | — | ↗ |
| 2021-06-09 | Stimart Tryn | Officer | S-Sale | D | Common Shares | 1,000,000 | 25.50 | 25.50M | 250 | — | ↗ |
| 2021-06-09 | Lecault Veronique | Director / Officer | S-Sale | D | Common Shares | 1,000,000 | 25.50 | 25.50M | 273,630 | — | ↗ |
| 2021-06-09 | Hansen Carl L. G. | Director / Officer / 10% Owner | S-Sale | D | Common Shares | 5,598,420 | 24.03 | 134.53M | 55,604,330 | — | ↗ |
| 2021-06-09 | Falconer Ester | Officer | S-Sale | D | Common Shares | 1,000,000 | 25.50 | 25.50M | 0 | — | ↗ |
| 2021-06-09 | Booth Andrew | Officer | S-Sale | D | Common Shares | 1,200,000 | 25.50 | 30.60M | 0 | — | ↗ |
| 2021-06-07 | Stimart Tryn | Officer | M-Exempt | A | Common Shares | 250,000 | 2.30 | 575.0K | 1,000,250 | — | ↗ |
| 2021-06-07 | Booth Andrew | Officer | M-Exempt | A | Common Shares | 600,000 | 0.19 | 114.0K | 600,000 | — | ↗ |
| 2021-03-19 | Falconer Ester | Officer | M-Exempt | A | Common Shares | 1,000,000 | 0.03 | 34.3K | 1,000,000 | — | ↗ |
| 2020-12-15 | THIEL PETER | Director | C-Conversion | D | Convertible Note | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-15 | Stimart Tryn | Officer | P-Purchase | A | Common Shares | 250 | 20.00 | 5.0K | 250 | — | ↗ |
| 2020-12-15 | Montalbano John S. | Director | P-Purchase | A | Common Shares | 20,000 | 20.00 | 400.0K | 20,000 | — | ↗ |
| 2020-12-15 | Lecault Veronique | Director / Officer | P-Purchase | A | Common Shares | 6,000 | 20.00 | 120.0K | 1,006,000 | — | ↗ |
| 2020-12-15 | Hayden Michael R | Director | C-Conversion | A | Common Shares | 117,647 | 17.00 | 2.00M | 1,103,397 | — | ↗ |
| 2020-12-15 | HAMER JOHN | Director / 10% Owner | C-Conversion | A | Common Shares | 29,411 | 17.00 | 500.0K | 29,105,761 | — | ↗ |
| 2020-12-15 | DCVC Bio, L.P. | 10% Owner | C-Conversion | D | Series A1 Preferred Shares | 2,105,264 | 0.00 | — | 0 | — | ↗ |
| 2020-12-11 | THIEL PETER | Director | — | I | Common Shares | 0 | 0.00 | — | 891,520 | — | ↗ |
| 2020-12-11 | Hayden Michael R | Director | — | D | Stock Option (right to buy) | 100,000 | 2.76 | 276.0K | 0 | — | ↗ |
| 2020-12-11 | HAMER JOHN | Director / 10% Owner | A-Award | A | Convertible Note | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-10 | Stimart Tryn | Officer | A-Award | A | Stock Option (right to buy) | 190,800 | 20.00 | 3.82M | 190,800 | — | ↗ |
| 2020-12-10 | Lecault Veronique | Director / Officer | A-Award | A | Stock Option (right to buy) | 190,800 | 20.00 | 3.82M | 190,800 | — | ↗ |
| 2020-11-18 | Montalbano John S. | Director | A-Award | A | Stock Option (right to buy) | 500,000 | 2.41 | 1.21M | 500,000 | — | ↗ |
| 2020-11-18 | Hayden Michael R | Director | A-Award | A | Stock Option (right to buy) | 100,000 | 2.76 | 276.0K | 100,000 | — | ↗ |
| 2020-11-06 | Hayden Michael R | Director | M-Exempt | D | Stock Option (right to buy) | 270,000 | 0.33 | 89.1K | 540,000 | — | ↗ |
| 2020-10-29 | Stimart Tryn | Officer | A-Award | A | Stock Option (right to buy) | 850,000 | 2.41 | 2.05M | 850,000 | — | ↗ |
| 2020-10-29 | Lecault Veronique | Director / Officer | A-Award | A | Stock Option (right to buy) | 2,000,000 | 2.41 | 4.82M | 2,000,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-3.0K
Shares Outstanding
303.16M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Carl L.G. Hansen, Ph.D. Chief Executive Officer | 550.0K | 357.9K | — | 5.36M | — | 23.2K | 6.29M | 85.20% | ↗ |
| 2 | 2025 | Andrew Booth Chief Financial Officer | 485.0K | 218.6K | — | 2.66M | — | 23.2K | 3.38M | 78.51% | ↗ |
| 3 | 2025 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer, Corporate Secretary, and Privacy Officer | 470.0K | 211.1K | — | 1.63M | — | 28.2K | 2.34M | 69.73% | ↗ |
| 4 | 2025 | Véronique Lecault, Ph.D. Chief Technology Officer | 454.0K | 204.4K | — | 1.63M | — | 23.2K | 2.32M | 70.56% | ↗ |
| 5 | 2024 | Carl L.G. Hansen, Ph.D. Chief Executive Officer | 460.0K | 263.8K | — | 7.50M | — | 23.0K | 8.25M | 90.94% | ↗ |
| 6 | 2024 | Andrew Booth Chief Financial Officer | 460.0K | 188.7K | — | 2.76M | — | 23.0K | 3.43M | 80.41% | ↗ |
| 7 | 2024 | Véronique Lecault, Ph.D. Chief Technology Officer | 460.0K | 184.7K | — | 2.76M | — | 23.0K | 3.42M | 80.50% | ↗ |
| 8 | 2024 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | 460.0K | 194.6K | — | 2.21M | — | 30.5K | 2.89M | 76.30% | ↗ |
| 9 | 2024 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer, Corporate Secretary, and Privacy Officer | 460.0K | 194.6K | — | 2.21M | — | 30.5K | 2.89M | 76.30% | ↗ |
| 10 | 2023 | Carl L.G. Hansen, Ph.D. Chief Executive Officer | 460.0K | 236.6K | — | — | — | 18.4K | 714.9K | 0.00% | ↗ |
| 11 | 2023 | Andrew Booth Chief Financial Officer | 460.0K | 191.7K | — | — | — | 22.8K | 674.6K | 0.00% | ↗ |
| 12 | 2023 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer | 460.0K | 180.1K | — | — | — | 27.6K | 667.7K | 0.00% | ↗ |
| 13 | 2023 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer, Corporate Secretary, and Privacy Officer | 460.0K | 180.1K | — | — | — | 27.6K | 667.7K | 0.00% | ↗ |
| 14 | 2023 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | 460.0K | 180.1K | — | — | — | 27.6K | 667.7K | 0.00% | ↗ |
| 15 | 2023 | Véronique Lecault, Ph.D. Chief Technology Officer | 460.0K | 167.8K | — | — | — | 22.8K | 650.6K | 0.00% | ↗ |
| 16 | 2023 | Véronique Lecault, Ph.D. Chief Operating Officer | 460.0K | 167.8K | — | — | — | 22.8K | 650.6K | 0.00% | ↗ |
| 17 | 2022 | Carl L.G. Hansen, Ph.D. Chief Executive Officer | 450.0K | 239.0K | — | 8.09M | — | 22.4K | 8.80M | 91.91% | ↗ |
| 18 | 2022 | Neil Aubuchon Chief Commercial Officer | 400.0K | 219.8K | 2.50M | 2.42M | — | 65.0K | 5.57M | 88.42% | ↗ |
| 19 | 2022 | Andrew Booth Chief Financial Officer | 450.0K | 170.0K | — | 4.25M | — | 22.4K | 4.89M | 86.86% | ↗ |
| 20 | 2022 | Véronique Lecault, Ph.D. Chief Technology Officer | 450.0K | 172.6K | — | 4.04M | — | 22.4K | 4.69M | 86.24% | ↗ |
| 21 | 2022 | Véronique Lecault, Ph.D. Chief Operating Officer | 450.0K | 172.6K | — | 4.04M | — | 22.4K | 4.69M | 86.24% | ↗ |
| 22 | 2022 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer | 450.0K | 167.4K | — | 3.03M | — | 27.0K | 3.68M | 82.47% | ↗ |
| 23 | 2022 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | 450.0K | 167.4K | — | 3.03M | — | 27.0K | 3.68M | 82.47% | ↗ |
| 24 | 2021 | Carl L.G. Hansen, Ph.D. Chief Executive Officer | 400.0K | 212.6K | — | 8.50M | — | 4.1K | 9.12M | 93.24% | ↗ |
| 25 | 2021 | Neil Berkley Chief Business Officer | 194.1K | 144.5K | 2.11M | 2.10M | — | 26.6K | 4.57M | 92.01% | ↗ |
| 26 | 2021 | Véronique Lecault, Ph.D. Chief Operating Officer | 400.0K | 159.5K | — | 3.75M | — | 4.1K | 4.31M | 86.93% | ↗ |
| 27 | 2021 | Andrew Booth Chief Financial Officer | 400.0K | 159.5K | — | 3.75M | — | 4.1K | 4.31M | 86.93% | ↗ |
| 28 | 2021 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | 400.0K | 156.8K | — | 2.50M | — | 7.0K | 3.06M | 81.60% | ↗ |
| 29 | 2021 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer | 400.0K | 156.8K | — | 2.50M | — | 7.0K | 3.06M | 81.60% | ↗ |
| 30 | 2021 | Tryn Stimart Chief Legal Officer, Chief Compl i ance Officer & Corporate Secretary | 400.0K | 156.8K | — | 2.50M | — | 7.0K | 3.06M | 81.60% | ↗ |
| 31 | 2020 | Carl L.G. Hansen, Ph.D. Chief Executive Officer | 296.2K | 128.5K | — | 16.54M | — | — | 16.96M | 97.50% | ↗ |
| 32 | 2020 | Véronique Lecault, Ph.D. Chief Operating Officer | 196.5K | 71.0K | — | 5.68M | — | — | 5.95M | 95.50% | ↗ |
| 33 | 2020 | Véronique Lecault, Ph D. Chief Operating Officer | 196.5K | 71.0K | — | 5.68M | — | — | 5.95M | 95.50% | ↗ |
| 34 | 2020 | Tryn T. Stimart Chief Legal Officer , Chief Compliance Officer & Corporate Secretary | 337.2K | 298.4K | — | 3.80M | — | — | 4.43M | 85.67% | ↗ |
| 35 | 2020 | Tryn Stimart Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | 337.2K | 298.4K | — | 3.80M | — | — | 4.43M | 85.67% | ↗ |
| 36 | 2020 | Tryn Stimart Chief Legal Officer, Chief Compl i ance Officer & Corporate Secretary | 337.2K | 298.4K | — | 3.80M | — | — | 4.43M | 85.67% | ↗ |
| 37 | 2019 | Tryn T. Stimart Chief Legal Officer , Chief Compliance Officer & Corporate Secretary | 115.2K | 17.5K | — | 519.2K | — | — | 651.9K | 79.65% | ↗ |
| 38 | 2019 | Carl L.G. Hansen, Ph.D. Chief Executive Officer | 177.4K | 72.5K | — | — | — | — | 249.9K | 0.00% | ↗ |
| 39 | 2019 | Tryn Stimart Chief Legal Officer, Chief Compl i ance Officer & Corporate Secretary | 115.2K | 17.5K | — | 519.2K | — | — | 870.00 | 59,680.23% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carl Hansen | Chief Executive Officer, President & Chairperson | 931.2K | — |
| Andrew Booth | Chief Financial Officer | 726.8K | male |
| Tryn T. Stimart | Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer | 709.3K | male |
| Veronique Lecault | Chief Technology Officer & Director | 681.6K | — |
| Martin Hogan | Senior Director of Strategic Finance & IR | — | male |
| Murray McCutcheon | Senior Vice President of Partnering | — | male |
| Tiffany Chiu | Vice President of Communications | — | female |
| Marcie Thiessen | Senior Director of Finance & Accounting | — | — |
| Andrew Knowles | Vice President of Operations | — | male |
| Caitlin Webster CIPD | Director of Talent Development | — | — |
| Adam Clarke | Senior Vice President of Discovery | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ABCL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
